[Hemodynamic effects of a new hypertensive agent (2',5'-dimethoxyphenyl-2 glycinamido-ethanol-1-hydrochlorid) following intravenous administration].
D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D001810:Blood Volume / Q000187:drug effects; D006328:Cardiac Catheterization; D002306:Cardiac Volume / Q000187:drug effects; D002986:Clinical Trials as Topic; D004983:Ethanolamines / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D006400:Hematocrit; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006873:Hydroquinones / Q000494:pharmacology; D007275:Injections, Intravenous; D008738:Methyl Ethers / Q000494:pharmacology; D008875:Middle Aged; D009130:Muscle, Smooth / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D011674:Pulse / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000494:pharmacology*
D004983:Ethanolamines; D006873:Hydroquinones; D008738:Methyl Ethers; D014662:Vasoconstrictor Agents; D009638:Norepinephrine
Hämodynamische Wirkungen einer neuen blutdrucksteigernden Substanz (2',5'-Dimethoxyphenyl-2-glycinamidoäthanol-1-hydrochlorid) nach intravenöser Verabreichung.